Pivotal bioVenture Partners Fund I G.P., L.P. - Insider Non-Derivative Transactions at Inozyme Pharma, Inc. (INZY) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 1, 2023, Pivotal bioVenture Partners Fund I G.P., L.P.'s relationship to Inozyme Pharma, Inc. (INZY) is Director, and currently has 2,923,110 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other INZY insiders.
Data Source: SEC.
Pivotal bioVenture Partners Fund I G.P., L.P. - Insider Non-Derivative Transactions at INZY
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 2, 2023 | P -- (Common Stock) | 714285 | 4.8 | 1571741 |
| Aug 2, 2023 | P -- (Common Stock) | 119048 | 4.8 | 2923110 |